Stay updated on Efficacy of Amifampridine in LEMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Amifampridine in LEMS Clinical Trial page.

Latest updates to the Efficacy of Amifampridine in LEMS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe new screenshot shows only minor UI/formatting updates with no changes to core study information such as title, conditions, interventions, outcomes, locations, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check43 days agoChange Detected- Added Eaton-Lambert syndrome and updated the page to revision v3.1.0. - Removed several related topics (Drug Safety, Lambert-Eaton myasthenic syndrome, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision v3.0.2.SummaryDifference0.8%

- Check58 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include new drug information and resources related to Amifampridine Phosphate and Lambert-Eaton myasthenic syndrome, while removing some previous location and drug classification details.SummaryDifference5%

Stay in the know with updates to Efficacy of Amifampridine in LEMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Amifampridine in LEMS Clinical Trial page.